538 related articles for article (PubMed ID: 16054568)
21. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
Rutkauskiene G; Labanauskas L
Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
[TBL] [Abstract][Full Text] [Related]
22. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP).
Rivera-Luna R; López E; Rivera-Marquez H; Rivera-Ortegón F; Altamirano-Alvarez E; Mercado G; Covarrubias G; Rueda-Franco F; Marhx-Bracho A; Gutiérrez P
Childs Nerv Syst; 2002 Feb; 18(1-2):38-42. PubMed ID: 11935242
[TBL] [Abstract][Full Text] [Related]
23. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
24. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
25. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
[TBL] [Abstract][Full Text] [Related]
26. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
27. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
28. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
30. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
31. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
[TBL] [Abstract][Full Text] [Related]
32. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
33. High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.
Bergthold G; El Kababri M; Varlet P; Dhermain F; Sainte-Rose C; Raquin MA; Kieffer V; Goma G; Grill J; Valteau-Couanet D; Dufour C
Pediatr Blood Cancer; 2014 May; 61(5):907-12. PubMed ID: 24470384
[TBL] [Abstract][Full Text] [Related]
34. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
[TBL] [Abstract][Full Text] [Related]
35. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
[TBL] [Abstract][Full Text] [Related]
36. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study.
Gentet JC; Bouffet E; Doz F; Tron P; Roche H; Thyss A; Plantaz D; Stephan JL; Mottolese C; Ponvert D
J Neurosurg; 1995 Apr; 82(4):608-14. PubMed ID: 7897523
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
Brandes AA; Franceschi E; Tosoni A; Blatt V; Ermani M
Cancer; 2007 Nov; 110(9):2035-41. PubMed ID: 17823910
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
[TBL] [Abstract][Full Text] [Related]
39. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
Verlooy J; Mosseri V; Bracard S; Tubiana AL; Kalifa C; Pichon F; Frappaz D; Chastagner P; Pagnier A; Bertozzi AI; Gentet JC; Sariban E; Rialland X; Edan C; Bours D; Zerah M; Le Gales C; Alapetite C; Doz F
Eur J Cancer; 2006 Nov; 42(17):3004-14. PubMed ID: 16956759
[TBL] [Abstract][Full Text] [Related]
40. Adult medulloblastoma: prognostic factors and patterns of relapse.
Chan AW; Tarbell NJ; Black PM; Louis DN; Frosch MP; Ancukiewicz M; Chapman P; Loeffler JS
Neurosurgery; 2000 Sep; 47(3):623-31; discussion 631-2. PubMed ID: 10981749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
